New Drug Target Identified In Deadly Form Of Leukemia
A research team led by the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia (CML), making it possible to develop drugs that may extend the survival of these patients...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Graduation | Health | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells